Press Releases keyboard_arrow_down
Media Coverage keyboard_arrow_down
Events keyboard_arrow_down
Blog keyboard_arrow_down
Webinars keyboard_arrow_down
Brochures keyboard_arrow_down

Media Relations

Bob Giuliano, T: +1 610-328-1051

Customer Contact

Deepak Prakash, T: + 1 773-294-3784

Aspen Medical Media Contacts

Lawrence Baumann, T:  +1 312-819-7248


Vancive Medical Technologies™ and Aspen Medical Sign Agreement for Distribution of Absorbent Wound Dressings in United Kingdom and Ireland

CHICAGO – October 20, 2014 – Vancive Medical Technologies™ and Aspen Medical Europe Ltd. (“Aspen Medical”) today announced an agreement for the exclusive distribution of the Vancive BeneHold™ Absorbent Wound Dressing portfolio in the United Kingdom and Ireland.


The BeneHold range comprises three product lines, each of which offers specific performance and value to the clinician and patient. The three product lines, which are available on the Drug Tariff as of October 1, 2014 are:


●      Thin Absorbent Wound Dressing featuring TASA™ (Thin Absorbent Skin Adhesive™);

●      Bordered Hydrocolloid Dressing with Odor Control (available in two advanced formulations); and the

●      Standard Hydrocolloid Dressing.


“We are pleased to have Aspen Medical as our partner, as we share a similar mission bringing innovative products to improve patient outcomes and patient experience with healthcare economics in mind,” said Howard Kelly, president and general manager of Vancive. “By adding technologies like TASA™ and advanced hydrocolloids that complement Aspen’s portfolio of advanced wound care products, we provide a comprehensive solution to meet the needs of the practitioner.”


The Bordered Hydrocolloid Dressing with Odor Control is formulated with non-cytotoxic cyclodextrins that capture odor molecules to help increase patient confidence. The dressings have a superior fluid handling capacity compared with existing products at equivalent thickness.


The Thin Absorbent Dressings are based on Vancive’s proprietary TASA™ (Thin Absorbent Skin Adhesive™) technology. At only 0.12mm, TASA™ dressings are less than half the thickness of other “thin” hydrocolloids. This translates to superior conformability, exceptional transparency and less opportunity for the dressing’s edge to lift off of the skin.


In early evaluations of the BeneHold™ Absorbent Wound Dressings, clinicians found that longer wear times can be achieved, especially on hard-to-dress or moisture-complicated areas. Nurses found them easy to work with, and patients found them to be comfortable to wear and atraumatic to remove. Because of its thinness, transparency, and the unique way it manages moisture, TASA™ was particularly well received.


“The Aspen Medical team looks forward to working with Vancive and its Benehold™ product range to provide wound care practitioners solutions that will help them meet their clinical challenges,” said Chris Hill, Sales and Marketing Director, Aspen Medical Europe Limited. “This technology, along with Vancive traditional and enhanced Hydrocolloids, is a good fit within our portfolio of products.  Hydrocolloid technology has an important and ongoing role to play in wound management.”


The products will be launched jointly by Vancive and Aspen Medical at the Wounds UK conference in Harrogate on 10-12 November.


Vancive Medical Technologies™, Vancive™, BeneHold™ and TASA™  (Thin Absorbent Skin Adhesive™) are trademarks of Avery Dennison Corporation.


About Vancive Medical Technologies

Vancive Medical Technologies makes inspired advances that lead to intelligent results. The business uses the most advanced adhesive and material technologies to create products that make healthcare easier for everyone. Vancive Medical Technologies is an Avery Dennison business headquartered in Chicago, Illinois. For more information, visit


About Avery Dennison

Avery Dennison (NYSE:AVY) is a global leader in labeling and packaging materials and solutions. The company’s applications and technologies are an integral part of products used in every major market and industry. With operations in more than 50 countries and 26,000 employees worldwide, Avery Dennison serves customers with insights and innovations that help make brands more inspiring and the world more intelligent. Headquartered in Glendale, California, the company reported sales from continuing operations of $6.1 billion in 2013.  Learn more at


About Aspen Medical

Aspen Medical Europe Ltd. (“Aspen Medical), a part of the Hill-Rom Corporation, is a manufacturer and distributor of leading brands within wound care, ophthalmic products, and surgical accessories.  They stock thousands of product lines and believe “every patient can benefit from an Aspen product.” Products include operating room safety products and accessories, high-quality blades and scalpels, ophthalmic cannulae, speciality needles, and advanced wound management products. With a focus on quality and customer service, Aspen Medical  operates globally.  They are the name behind “trusted brands” such as Steriseal®, Sorbsan®, C-View™, and Sorbaderm™.  Learn more at




© 2016 Avery Dennison Corporation, All Rights Reserved.

Various trademarks and trade names are used herein and are the property of their respective owners.